Ignite Creation Date:
2025-12-25 @ 5:12 AM
Ignite Modification Date:
2026-02-19 @ 4:00 PM
Study NCT ID:
NCT06816927
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-06-29
First Post:
2024-12-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab
Sponsor:
Duke University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Pro00116940
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None